Multiple Myeloma Program

Multiple Myeloma Patient Symposium

Our latest symposium covers therapeutic advances in multiple myeloma, CAR T cell and bispecific antibody therapy, and more.

View Symposium Recordings

The Jerome Lipper Multiple Myeloma Center provides comprehensive care to patients with multiple myeloma, including promising new therapies through clinical trials rooted in an approach that brings laboratory discoveries quickly to the clinical setting. We conduct an active program of basic and clinical research aimed at improving the outcomes of multiple myeloma.

Our Treatment Approach

We provide a comprehensive range of services for patients, including:

Early Detection and Prevention of Multiple Myeloma

Our Center for Early Detection and Interception of Blood Cancers (formerly the Center for Prevention of Progression) cares for patients diagnosed with – or at high risk for – precursor conditions of multiple myeloma such as MGUS and smoldering myeloma. The clinic works with patients to manage their risk of disease progression and offers clinical trials of early intervention therapies to prevent disease progression.

Services and Support at Dana-Farber

new-patient-coordinators556x381.jpg

Becoming Our Patient

As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.

blum-center-2024-556x381.jpg

Resources and Support Services Directory

We offer a wide range of support programs and resources for patients, caregivers, and loved ones. Our supportive services are designed to help you navigate your care experiences with greater comfort and ease.

leslie-lehmann-and-patient-556x381.jpg

Why Choose Dana-Farber

Each year, thousands of patients from around the world come to Dana-Farber for their cancer care. Find out why.